Patient state of knowledge on biosimilars – do physicians need to improve education skills?
Availability of biosimilar medicines is rapidly increasing, potentially leading to a wider prescription and a support for healthcare system costs. Despite efforts of patient and physician educational initiatives there still remains a reluctance in prescribing or administering this type of products....
Main Authors: | Claudia Cobilinschi, Daniela Opris-Belinski, Catalin Codreanu, Razvan Ionescu, Magda Parvu, Claudia Mihailov, Horatiu Popoviciu, Codrina Ancuta, Elena Rezus, Ioana Saulescu, Sanziana Daia-Iliescu, Laura Groseanu, Ruxandra Ionescu |
---|---|
Format: | Article |
Language: | English |
Published: |
Amaltea Medical Publishing House
2020-06-01
|
Series: | Romanian Journal of Rheumatology |
Subjects: | |
Online Access: | https://rjr.com.ro/articles/2020.2/RJR_2020_2_Art-05.pdf |
Similar Items
Similar Items
-
Nocebo in Biosimilars and Generics in Neurology: A Systematic Review
by: Ioanna Spanou, et al.
Published: (2019-07-01) -
The role of the Nocebo effect in the use of biosimilars in routine rheumatology clinical practice
by: Evrydiki Kravvariti, et al.
Published: (2019-01-01) -
Nonmedical Switching From Originators to Biosimilars: Does the Nocebo Effect Explain Treatment Failures and Adverse Events in Rheumatology and Gastroenterology?
by: Roy Fleischmann, et al.
Published: (2020-01-01) -
Biosimilars in the management of chronic inflammatory diseases: The Dutch experience
by: Wieland D. Müskens, et al.
Published: (2019-01-01) -
The Clinical Implications of Nocebo Effects for Biosimilar Therapy
by: Luana Colloca, et al.
Published: (2019-11-01)